JAVELIN Bladder 100: Avelumab first-line maintenance plus best supportive care (BSC) versus BSC alone for advanced UC

Dose-escalation of mosunetuzumab with polatuzumab vedotin for R/R B-cell non-Hodgkin’s lymphoma

Efficacy and safety of tisagenlecleucel in adult patients with relapsed/refractory follicular lymphoma

Clinical research and trials in Romania

Medical and scientific days of The Institute of Oncology Bucharest 2021 : Steps to the Oncology of Tomorrow

Advances in lung cancer and current situation in Romania

First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukaemia

Breast cancer roundup from ASCO 2021

CAPTIVATE: First-line ibrutinib plus venetoclax for CLL/SLL

Interim results of a phase II study of blinatumomab plus ponatinib for Philadelphia chromosome-positive ALL

Phase II study of blinatumomab for MRD-positive B-cell acute lymphoblastic leukaemia

EHA 2021: Latest in immunotherapy for R/R multiple myeloma